pillbase.ru

KEVZARA

Active substance: sarilumab

INJECTION, SOLUTION · SARILUMAB 200 mg/1.14mL

United StatesActive

Marketing holder: Sanofi-Aventis U.S. LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Кевзара®
    раствор для подкожного введения, 175 мг/мл, 1.14 мл (original in Russian, GRLS)
    ЛП-005185
    АО "Санофи-авентис груп"
EU 1
  • Kevzara
    sarilumab
    EMEA/H/C/004254
    Sanofi Winthrop Industrie
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c4-b9f5-7478-bac1-97bf5c5ca4ee;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-4ca9-76e2-a12d-804fe20f1d7b,01a12093-d97e-7377-947f-b022c08aade6,01a12093-dbc3-7283-89ba-7506155ac6c3,01a1209d-9bf0-7aee-83bc-34422326e0aa;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0024-5922
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 0024-5922 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0024-5922 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0024-5922 · Verified 2026-10-09 · open in source